United States securities and exchange commission logo





                             May 12, 2020

       William Hoffman
       Chief Executive Officer
       Inari Medical, Inc.
       9 Parker, Suite 100
       Irvine, CA 92618

                                                        Re: Inari Medical, Inc.
                                                            Amendment No. 1 to
Registration Statement on Form S-1
                                                            Filed May 5, 2020
                                                            File No. 333-236568

       Dear Mr. Hoffman:

            We have reviewed your amended registration statement and have the
following
       comment.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comment applies to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.

       Amendment No. 1 to Form S-1 filed on May 5, 2020

       Condensed Statements of Operations, page F-32

   1.                                                   Please revise the
filing to present pro forma basic and diluted earnings per share for your
                                                        latest interim period,
March 31, 2020, similar to the presentation included on page F-4 for
                                                        your fiscal year-end.
 William Hoffman
FirstName LastNameWilliam Hoffman
Inari Medical, Inc.
Comapany NameInari Medical, Inc.
May 12, 2020
Page 2
May 12, 2020 Page 2
FirstName LastName
       You may contact Jeanne Bennett at (202) 551-3606 or Kevin Kuhar at (202)
551-3662 if
you have questions regarding comments on the financial statements and related
matters. Please
contact Chris Edwards at (202) 551-6761 or Irene Paik at (202) 551-6553 with
any other
questions.



                                                          Sincerely,

                                                          Division of
Corporation Finance
                                                          Office of Life
Sciences
cc:      J. Ross McAloon